Multiple models testing prediction of long-term outcomes by serum ferritin combined with FIB-4 to predict long-term outcomes
Method | Liver-related events (103/1324) | HCC (23/1322) | Cardiovascular events (135/1254) | Extrahepatic cancer (94/1104) | Mortality (66/1334) |
Cox regression | 0.718±0.001* | 0.825±0.008 | 0.57±0.007 | 0.544±0.012 | 0.652±0.018* |
Lasso-penalised Cox regression | 0.711±0.005* | 0.829±0.008 | 0.627±0.006 | 0.512±0.011 | 0.632±0.013* |
Ridge-penalised Cox regression | 0.72±0.002* | 0.834±0.009* | 0.601±0.004 | 0.543±0.009 | 0.641±0.017* |
Elastic net-penalised Cox regression | 0.72±0.005* | 0.829±0.008 | 0.639±0.006 | 0.514±0.011 | 0.63±0.016 |
Median Harrell’s C-indices with corresponding standard errors of the median estimated on the test sets of the cross-validation. Cox proportional hazard model and its penalised variants (i.e., Lasso, Ridge and Elastic Net) were applied. The ratio number of events/total number for each outcome is reported on top into brackets.
*Reporting statistically higher C-indices with respect to the same model tested on the same cross-validation split but considering only confounders, according to the one-sided Wilcoxon signed rank test (p value <0.05).
FIB-4, Fibrosis-4; HCC, hepatocellular carcinoma.